149 related articles for article (PubMed ID: 9399104)
1. Mechanisms involved in activation of human eosinophil exocytosis by substance P: an in vitro model of sensory neuroimmunomodulation.
el-Shazly AE; Masuyama K; Ishikawa T
Immunol Invest; 1997; 26(5-7):615-29. PubMed ID: 9399104
[TBL] [Abstract][Full Text] [Related]
2. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
[TBL] [Abstract][Full Text] [Related]
3. Role of pertussis toxin-sensitive G proteins in stimulus-dependent human eosinophil degranulation.
Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
J Immunol; 1991 Nov; 147(10):3466-73. PubMed ID: 1719078
[TBL] [Abstract][Full Text] [Related]
4. Immunoregulatory effect of substance P in human eosinophil migratory function.
El-Shazly AE; Masuyama K; Eura M; Ishikawa T
Immunol Invest; 1996 May; 25(3):191-201. PubMed ID: 9157054
[TBL] [Abstract][Full Text] [Related]
5. Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.
El-Shazly A; Ishikawa T
Mediators Inflamm; 1999; 8(3):177-9. PubMed ID: 10704057
[TBL] [Abstract][Full Text] [Related]
6. Pimecrolimus reduces eosinophil activation associated with calcium mobilization.
Plager DA; Henke SA; Matsuwaki Y; Madaan A; Squillace DL; Dierkhising RA; Kita H
Int Arch Allergy Immunol; 2009; 149(2):119-26. PubMed ID: 19127068
[TBL] [Abstract][Full Text] [Related]
7. Regulatory effect of cytokines on eosinophil degranulation.
Fujisawa T; Abu-Ghazaleh R; Kita H; Sanderson CJ; Gleich GJ
J Immunol; 1990 Jan; 144(2):642-6. PubMed ID: 2104901
[TBL] [Abstract][Full Text] [Related]
8. Eosinophil major basic protein induces degranulation and IL-8 production by human eosinophils.
Kita H; Abu-Ghazaleh RI; Sur S; Gleich GJ
J Immunol; 1995 May; 154(9):4749-58. PubMed ID: 7722326
[TBL] [Abstract][Full Text] [Related]
9. [Eosinophil granule proteins (MBP, ECP, EPX/EDN, EPO)--a possible process of eosinophil activation and degranulation].
Tsuda S; Miyasato M
Nihon Rinsho; 1993 Mar; 51(3):613-9. PubMed ID: 8492433
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C.
Egesten A; Malm J
Allergy; 1998 Nov; 53(11):1066-73. PubMed ID: 9860239
[TBL] [Abstract][Full Text] [Related]
11. Urinary eosinophil-derived neurotoxin/protein X: a simple method for assessing eosinophil degranulation in vivo.
Cottin V; Deviller P; Tardy F; Cordier JF
J Allergy Clin Immunol; 1998 Jan; 101(1 Pt 1):116-23. PubMed ID: 9449510
[TBL] [Abstract][Full Text] [Related]
12. Release of granule proteins from eosinophils cultured with IL-5.
Kita H; Weiler DA; Abu-Ghazaleh R; Sanderson CJ; Gleich GJ
J Immunol; 1992 Jul; 149(2):629-35. PubMed ID: 1624806
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of non-selective and selective phosphodiesterase inhibitors on human eosinophil functions.
Hatzelmann A; Tenor H; Schudt C
Br J Pharmacol; 1995 Feb; 114(4):821-31. PubMed ID: 7539697
[TBL] [Abstract][Full Text] [Related]
14. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
Hirayama Y; Lei YH; Barnes PJ; Rogers DF
Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
[TBL] [Abstract][Full Text] [Related]
15. Regulation of Ig-induced eosinophil degranulation by adenosine 3',5'-cyclic monophosphate.
Kita H; Abu-Ghazaleh RI; Gleich GJ; Abraham RT
J Immunol; 1991 Apr; 146(8):2712-8. PubMed ID: 1707917
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptides modulate human eosinophil chemotaxis.
Numao T; Agrawal DK
J Immunol; 1992 Nov; 149(10):3309-15. PubMed ID: 1385521
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations.
Zeck-Kapp G; Kroegel C; Riede UN; Kapp A
Allergy; 1995 Jan; 50(1):34-47. PubMed ID: 7741187
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of protein kinases A and C demonstrates dual modes of response in human eosinophils stimulated with platelet-activating factor.
Takizawa T; Kato M; Kimura H; Suzuki M; Tachibana A; Obinata H; Izumi T; Tokuyama K; Morikawa A
J Allergy Clin Immunol; 2002 Aug; 110(2):241-8. PubMed ID: 12170264
[TBL] [Abstract][Full Text] [Related]
19. Release of granule proteins from human eosinophils stimulated with mast-cell mediators.
Takafuji S; Tadokoro K; Ito K; Nakagawa T
Allergy; 1998 Oct; 53(10):951-6. PubMed ID: 9821474
[TBL] [Abstract][Full Text] [Related]
20. The influence of IL-3, IL-5, and GM-CSF on normal human eosinophil and neutrophil C3b-induced degranulation.
Carlson M; Peterson C; Venge P
Allergy; 1993 Aug; 48(6):437-42. PubMed ID: 8238799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
